Guidant of Indianapolis has received U.S. FDA approval to market the Multi-Link Ultra Coronary Stent System, which is designed specifically for the treatment of larger native coronary arteries.
Like its predecessor the Multi-Link, the stent has the ability to cover a larger surface area of atherosclerotic plaque that is generally found in large diameter vessels. It is also designed to conform to the natural curvatures of the vessel that it’s implanted in, according to the company.
The stent ranges in size from 3.5 to 5 mm and is indicated for use in first-time and restonotic lesions in native coronary arteries, as well as for abrupt or threatened closure.
By AuntMinnie.com staff writersSeptember 11, 2000
Related Reading
Guidant launches peripheral stent trial, August 30, 2000
Boston Scientific, Guidant bury hatchet, May 17, 2000
C.R. Bard joins Global Healthcare Exchange, May 3, 2000
Radiance posts higher revenues, lower sales, May 5, 2000
Copyright © 2000 AuntMinnie.com
